Abstracts

877 – Statins Reduce Frailty in People With HIV

Background Statins have pleiotropic effects beyond lowering LDL cholesterol, offering benefits in multiple cardiometabolic conditions and reducing chronic inflammation. These effects have the potential to also influence biological aging trajectories, reflected by frailty. The objective of this study was to compare frailty trajectories, in people with HIV (PWH) who used statins for primary cardiovascular prevention…

804 – Low-Level HIV Viremia Increases Immunosuppressive Markers Elevating Cancer and CVD Risk in InSTI Era

Background We previously reported that low-level viremia (LLV) (50-200 copies/mL) increases cellular activation and senescence in people with HIV (PWH), phenomena closely related to the development of cancer and cardiovascular diseases (CVD). However, data on the clinical consequences of LLV remain limited, especially in the integrase strand transfer inhibitors (INSTI) era. Our aim was to explore…

872 – Mitochondrial DNA Variation and Physical Function Among Men With and Without HIV

Background Mitochondrial DNA variation is associated with multiple aging-related comorbidities among people with HIV (PWH). Data on the effect of inherited mitochondrial DNA variants on physical function among PWH are limited. Methods We included men with ≥2 visits from the Multicenter AIDS Cohort Study. Gait speed and grip strength were evaluated twice annually using standard methods…

858 – Associations Between Antiretroviral Therapy Use, Vitamin C Renal Leak, and Vitamin C Deficiency

Background Reduced vitamin C concentrations (vitC) in HIV are associated with abnormal urinary loss: a renal leak. Renal leak indicates an underlying disease-related nutritional dysregulation independent of dietary intake. While ART use is associated with renal tubular dysfunction, there is insufficient understanding of the relationships between ART class, renal leak and reduced vitC concentrations.  Methods…